| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1416 | 1.690 |
Why?
|
| RNA Helicases | 3 | 2023 | 76 | 1.550 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 100 | 1.490 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 69 | 1.420 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 483 | 1.370 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 418 | 1.200 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 135 | 0.990 |
Why?
|
| Prostate | 6 | 2014 | 415 | 0.930 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 189 | 0.930 |
Why?
|
| Neoplasms | 5 | 2023 | 2967 | 0.910 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.810 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 344 | 0.810 |
Why?
|
| Guanidines | 1 | 2022 | 24 | 0.760 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 46 | 0.760 |
Why?
|
| Keto Acids | 1 | 2022 | 50 | 0.750 |
Why?
|
| Transaminases | 1 | 2022 | 36 | 0.750 |
Why?
|
| Stromal Cells | 6 | 2014 | 314 | 0.710 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 35 | 0.710 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 38 | 0.710 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 1988 | 0.650 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 363 | 0.620 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 463 | 0.620 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 305 | 0.600 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 343 | 0.600 |
Why?
|
| Inflammation | 4 | 2022 | 1488 | 0.580 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 4 | 0.560 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 287 | 0.560 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 136 | 0.530 |
Why?
|
| Retroviridae | 1 | 2017 | 182 | 0.510 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 3671 | 0.490 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 105 | 0.490 |
Why?
|
| Mice | 17 | 2022 | 18472 | 0.420 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1775 | 0.400 |
Why?
|
| Animals | 20 | 2022 | 34332 | 0.340 |
Why?
|
| Mice, SCID | 2 | 2022 | 579 | 0.320 |
Why?
|
| Androgens | 3 | 2023 | 272 | 0.300 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2644 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 611 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 254 | 0.270 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 49 | 0.260 |
Why?
|
| Proteins | 4 | 2014 | 1026 | 0.250 |
Why?
|
| Signal Transduction | 4 | 2023 | 4665 | 0.230 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 114 | 0.230 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 57 | 0.230 |
Why?
|
| Carcinoma | 1 | 2007 | 283 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 293 | 0.210 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.190 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 707 | 0.190 |
Why?
|
| Humans | 21 | 2023 | 131379 | 0.190 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 4 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 2604 | 0.180 |
Why?
|
| Staphylococcus | 1 | 2001 | 68 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 135 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3862 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 989 | 0.170 |
Why?
|
| Protein Conformation | 3 | 2003 | 810 | 0.170 |
Why?
|
| Th1 Cells | 1 | 2021 | 156 | 0.160 |
Why?
|
| Th17 Cells | 1 | 2021 | 95 | 0.160 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 140 | 0.160 |
Why?
|
| Kupffer Cells | 1 | 2020 | 20 | 0.160 |
Why?
|
| Cell Survival | 1 | 2022 | 853 | 0.160 |
Why?
|
| Mice, Nude | 5 | 2014 | 714 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 359 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 59 | 0.150 |
Why?
|
| Hepatitis | 1 | 2020 | 57 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 1000 | 0.150 |
Why?
|
| Male | 15 | 2023 | 65099 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 428 | 0.150 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 518 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4762 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 234 | 0.150 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 199 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2021 | 808 | 0.140 |
Why?
|
| DNA Repair | 1 | 2021 | 563 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 527 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 235 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 127 | 0.130 |
Why?
|
| Calcium | 1 | 2022 | 1041 | 0.130 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 261 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 4686 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 164 | 0.130 |
Why?
|
| Ribosomes | 1 | 1997 | 124 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 760 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 138 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 110 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 108 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 262 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 765 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Pteridines | 1 | 2014 | 10 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 14 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 515 | 0.110 |
Why?
|
| Kallikreins | 1 | 2014 | 26 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2020 | 678 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 403 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 40 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2014 | 62 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 122 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 2203 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 226 | 0.100 |
Why?
|
| Nitriles | 1 | 2014 | 164 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2362 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 236 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 209 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 152 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 414 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1018 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 530 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 329 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 451 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1236 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2015 | 354 | 0.090 |
Why?
|
| Apoptosis | 2 | 2017 | 1862 | 0.090 |
Why?
|
| Ganglia | 1 | 2010 | 15 | 0.080 |
Why?
|
| Wound Healing | 1 | 2014 | 476 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2568 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 663 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1522 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 120 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 579 | 0.070 |
Why?
|
| Female | 3 | 2022 | 71018 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 119 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2464 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1794 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1541 | 0.060 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 699 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 20 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 496 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 477 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 60 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 89 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 14 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1262 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 172 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 1203 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1087 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 66 | 0.040 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 2 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2001 | 141 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1488 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 237 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1610 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 486 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 64 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 181 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 722 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 725 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 189 | 0.030 |
Why?
|
| Coleoptera | 1 | 1997 | 11 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 300 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1710 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1008 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 165 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 191 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 292 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 785 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 410 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 875 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 51 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 99 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 58 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1312 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 233 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 310 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 245 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2015 | 221 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 349 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1397 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 665 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 984 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 307 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6271 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4516 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 1559 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 739 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 676 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 609 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2376 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1831 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 999 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1945 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 230 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 2783 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 199 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 998 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12915 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1386 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 149 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 25 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 83 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 249 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 50 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 367 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 286 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 361 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 159 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 365 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 147 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 230 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2970 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 357 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6178 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 10080 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 781 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3613 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 31618 | 0.010 |
Why?
|